Related content

Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy

By Zhang Xue   Diasio Robert B  

Pharmacogenomics, Vol. 8, Iss. 3, 2007-03 ,pp. : 257-265

Future Medicine

Access to resources Recommend Favorite

Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity

By Amstutz Ursula   Froehlich Tanja K   Largiadèr Carlo R  

Pharmacogenomics, Vol. 12, Iss. 9, 2011-09 ,pp. : 1321-1336

Future Medicine

Access to resources Recommend Favorite

Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment

By Amstutz Ursula   Farese Simone   Aebi Stefan   Largiadèèr Carlo R  

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 931-944

Future Medicine

Access to resources Recommend Favorite

The Effect of Dihydropyrimidine Dehydrogenase Deficiency on Outcomes with Fluorouracil

By Gardiner S.J.  

Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol. 21, Iss. 1-2, 2002-01 ,pp. : 1-16

Adis International

Access to resources Recommend Favorite

Intratumoural Thymidylate Synthase and Dihydropyrimidine Dehydrogenase Activities Are Good Predictors of 5-Fluorouracil Sensitivity in Colorectal Cancer

By Ishibiki Y   Kitajima M   Sakamoto K   Tomiki Y   Sakamoto S   Kamano T  

The Journal of International Medical Research, Vol. 31, Iss. 3, 2003-05 ,pp. : 181-187

Field House Publishing

Access to resources Recommend Favorite